Spectacular failures. And the market id telling us loudly and clearly that hifu is worthless.
In my opinion, EDAP is a fantastic investment. They are on the cusp of a breakout. They are profitable with PLENTY of cash (Over 22 million). Their sales are INCREASING, with C code for insurance reimbursement they are going to increase SIGNIFICANTLY. I'm happy with the products and the management. EDAP is one of the best run companies I've ever seen. Patience will be rewarded. I see EDAP's share price hitting double digits before year end. Good luck to all !
I only $2.90 the stock should be anywhere from 5 to $10 a share now
So now it's just as if that code approval never happened. Still at an abysmal level. You just can't get past incompetent, failed management and that's now clear to everyone. And the pathetic management shill just highlights that with his drivel and silly posting of eight approvals immediately after he posts his nonsense. Olcashowitz should be so embarrassed that that kind of junk is posted in support of his truly failed tenure.
The actions of management strongly support my thesis since it is obvious that they don't believe the company has a long-range future. They have twice gone to the well with placements for cash they didn't really need diluting the stock by 100% in the process. They don't own any stock so that was fine with them. But now they can carry on drawing undeserved salaries and losing a couple of million a year for a dozen more years.
Reimbursement, WOW THAT WAS QUICK...
Great news, and excited it starts on July 1st.
Can you please provide me the exact scope of the reimbursement. Will this be the USA and for all medical insurance companies?
IMPORTANT QUOTE FROM CONFERENCE CALL LAST WEEK "Private or commercial insurers may also recognize and accept C-Code."
"I would like to further clarify what a C-CODE as the reimbursement process is complicated and might generate some confusion because our unique temporary pricing code that CMS initially established for hospitals to report from services and their the hospital outpatient prospective payment system or PPS equals are used on Medicare or PPS but may also be recognized on claims from other providers or by other payment systems. In CMS, originally established then C-Codes have evolved and they also now target unique hospital services that may be provided by OPPs providers or providers paid under the other payment system. Private or commercial insurers may also recognize and accept C-Code. The C-Code is likely to cover only the HIFU facility payment for HIFU ablation, the hospital may receive additional payment for other services and the physicians and the physiology (phon) fees will be billed and paid separately. We should have feedback and a decision from CMS during June for an effective date of this decision by July 1, 2017." Transcript courtesy of Seeking Alpha.
I'm in and can't wait to see the rest of the year ...
Management has certainly been completely incompetent, but let's be fair here. At this point the technology and this company are no longer obscure. Thus the only rational conclusion would be that most knowledgeable players have concluded that hifu has no real future.
I have $15,500 shares for sale for $20 a share first come first serve
Should be over 4 by now. Instead no trades for half an hour because of those 7100 shares for sale at 3 that we can't get by.
It should be a done deal for positive decision. There is no reason for insurance company pay more for radiation and surgery.
http: Specialiste-en-urologie.fr INTRO : Concept We are going to present to you the use of 3D Keolis cartography during Hifu focal one treatment procedure. T...
Still in the toilet at 3 after this news? Something badly wrong here.
LYON, France, May 22, 2017 (GLOBE NEWSWIRE) -- EDAP TMS SA (EDAP), the global leader in therapeutic ultrasound, announced today that the Centers for Medicare and Medicaid Services (CMS) have established a new billing code for HIFU ablation of prostate tissue. A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/a94c40ad-b3a4-4d46-a5e7-a73a4873fcf9 "We are elated by CMS's decision," said Marc Oczachowski, EDAP's Chief Executive Officer. “This is another key milestone in the acceptance and recognition of HIFU technology in the U.S. as reflected by CMS’s celerity in addressing the dossier, establishing a c-code and assigning a competitive coverage level. It will provide a choice between recognized therapies based solely on clinical need and evidence. The C-code is a significant achievement and opens the door to broader coverage from different payers, including private and commercial payers. We will now transition our efforts toward expanding coverage and physician education to make our innovative technology available to all patients in the U.S.” HIFU ablation of prostate tissue procedures have been assigned C-code 9747 - ambulatory payment classification (APC) 5376; the code will take effect July 1st, 2017. C-codes are unique, temporary pricing codes initially established for the Hospital Outpatient Prospective Payment System (OPPS). The C-codes are used on Medicare OPPS claims, and may also be recognized on claims from other providers or by other payment systems. The code is applicable to all procedures performed by the Company's HIFU devices, including whole primary whole gland prostate ablation, partial prostate ablation or whole and partial salvage ablation. Mr. Ozachowski added, “I would like to thank Jerry Stringham, president of the reimbursement strategy consulting firm Medical Technology Partners for all of his hard work. Jerry has been instrumental in directing our efforts towards reimbursement. We look forward to continuing to work with his experienced team while we pursue additional reimbursement for HIFU procedures.”
Reimbursement decision in 2-3 weeks.
Hey, where's Drop Dead ED in the last couple of days? Maybe he\she is taking a break now that EDAP teamed up with Sonocare to get the C code from CMS.